Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Halina Offner

Showing results (131-140 of 162) with videos related to

Pageof 17
Sort By:
Translational Stroke Research|December 19, 2016
DRα1-MOG-35-55 Reduces Permanent Ischemic Brain InjuryJianyi Wang, Qing Ye, Jing Xu, et al.
European Journal of Immunology|April 29, 2004
Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic miceCathleen Rich, Jason M Link, Alex Zamora, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 20, 2009
An orally bioavailable synthetic analog of an active dehydroepiandrosterone metabolite reduces established disease in rodent models of rheumatoid arthritisHalina Offner, Gary S Firestein, David L Boyle, et al.
Journal of Neuroimmunology|August 6, 2017
Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cellsGil Benedek, Jun Zhang, Ha Nguyen, et al.
Journal of Neurochemistry|August 11, 2006
Antigen-specific therapy promotes repair of myelin and axonal damage in established EAEChunhe Wang, Bruce G Gold, Laurie J Kaler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 16, 2007
A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNSSushmita Sinha, Sandhya Subramanian, Thomas M Proctor, et al.
European Journal of Immunology|April 7, 2011
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexesRony Dahan, Moran Tabul, Yuan K Chou, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 1, 2009
Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOGSushmita Sinha, Sandhya Subramanian, Ashley Emerson-Webber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2010
Estradiol and G1 reduce infarct size and improve immunosuppression after experimental strokeBing Zhang, Sandhya Subramanian, Suzan Dziennis, et al.
Journal of Neuroimmunology|June 16, 2010
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitisSushmita Sinha, Lisa Miller, Sandhya Subramanian, et al.
Pageof 17

Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Translational Stroke Research|December 19, 2016
DRα1-MOG-35-55 Reduces Permanent Ischemic Brain InjuryJianyi Wang, Qing Ye, Jing Xu, et al.
European Journal of Immunology|April 29, 2004
Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic miceCathleen Rich, Jason M Link, Alex Zamora, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 20, 2009
An orally bioavailable synthetic analog of an active dehydroepiandrosterone metabolite reduces established disease in rodent models of rheumatoid arthritisHalina Offner, Gary S Firestein, David L Boyle, et al.
Journal of Neuroimmunology|August 6, 2017
Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cellsGil Benedek, Jun Zhang, Ha Nguyen, et al.
Journal of Neurochemistry|August 11, 2006
Antigen-specific therapy promotes repair of myelin and axonal damage in established EAEChunhe Wang, Bruce G Gold, Laurie J Kaler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 16, 2007
A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNSSushmita Sinha, Sandhya Subramanian, Thomas M Proctor, et al.
European Journal of Immunology|April 7, 2011
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexesRony Dahan, Moran Tabul, Yuan K Chou, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 1, 2009
Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOGSushmita Sinha, Sandhya Subramanian, Ashley Emerson-Webber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2010
Estradiol and G1 reduce infarct size and improve immunosuppression after experimental strokeBing Zhang, Sandhya Subramanian, Suzan Dziennis, et al.
Journal of Neuroimmunology|June 16, 2010
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitisSushmita Sinha, Lisa Miller, Sandhya Subramanian, et al.
Pageof 17